Catalyst Wire Dossier Catalyst Wire Dossier

Sekanjabin e Safarjali

Quince Oxymel
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sekanjabin e Safarjali, covering 2014-07-10 to 2014-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks [NA]

See pricing